Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
06/2010
06/03/2010WO2010036395A3 Treatment of organophosphate exposure with tetrahydroindolone arylpiperazine compounds
06/03/2010WO2010028213A3 N-sulfonamido polycyclic pyrazolyl compounds
06/03/2010WO2010020920A3 Anti-parkinsonian compound acetylsalicylic acid maltol ester
06/03/2010WO2010014257A3 Tetrahydropyridinyl and dihydropyrrolyl compounds and the use thereof
06/03/2010WO2010009210A3 Acetylsalicyclic acid derivatives useful to treat metabolic syndromes
06/03/2010WO2010007165A3 Treatment of inflammatory diseases with mammal beta defensins
06/03/2010WO2009100351A3 Delivery of rnai constructs to oligodendrocytes
06/03/2010US20100138942 Use of the augmenter of liver regeneration protein as an apoptosis regulator
06/03/2010US20100137448 Methods for Treating Neuropsychiatric Disorders with NMDA Receptor Antagonists
06/03/2010US20100137447 Method for the production of adsorbates of a rasagiline salt having a water-soluble adjuvant
06/03/2010US20100137446 Naphthalene compounds, a process for their preparation and pharmaceutical compositions containing them
06/03/2010US20100137442 Sustained Release Particulate Oral Dosage Forms of (R)-Baclofen and Methods of Treatment
06/03/2010US20100137438 Isovaline for treatment of pain
06/03/2010US20100137429 Composition for transdermal or transmucosal administration
06/03/2010US20100137428 Oxygen containing heterocycles as glycine transporter inhibiting compounds
06/03/2010US20100137403 Method for enhancing cognition or inhibiting cognitive decline
06/03/2010US20100137402 N-[(4,5-diphenyl-2-thienyl)methyl]amine derivatives, their preparation and their therapeutic application
06/03/2010US20100137390 1,3-Dihydroimidazole-2-Thione Derivatives as Inhibitors of Dopamine-Beta-Hydroxylase
06/03/2010US20100137387 Beta-keto-amide derivatives useful as ion channel modulators
06/03/2010US20100137381 Acetamide derivatives as potassium channel modulators
06/03/2010US20100137370 Use of 4 cyclopropylmethoxy-n-(3,5 dichloro-1 oxido-pyridin-4 yl)-5-(methoxy)pyridine-2 carboxamide for the treatment of spinal cord traumas
06/03/2010US20100137368 Pyridine derivatives as fast dissociating dopamine 2 receptor antagonists
06/03/2010US20100137363 Substituted Indoles And Methods Of Their Use
06/03/2010US20100137359 Caspase inhibitors and uses thereof
06/03/2010US20100137352 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders
06/03/2010US20100137345 Prophylactic and therapeutic use of sirtuin inhibitors in tnf-alpha mediated pathologies
06/03/2010US20100137344 Induction of analgesia in neuropathic pain
06/03/2010US20100137340 Fused pyrimidinone compounds as mglur ligands
06/03/2010US20100137339 Amorphous form of n--n-methyl-acetamide
06/03/2010US20100137336 Novel amido derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
06/03/2010US20100137332 Piperazine modulators of nk-1 receptors
06/03/2010US20100137331 Quinolines Useful as Modulators of ION Channels
06/03/2010US20100137329 Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme
06/03/2010US20100137328 Tricyclic anilide heterocyclic cgrp receptor antagonists
06/03/2010US20100137327 Novel semicarbazide and carbonylhydrazide derivatives useful as potassium channel modulators
06/03/2010US20100137324 Rho-kinase inhibitors
06/03/2010US20100137322 Novel n-(8-heteroaryltetrahydronaphtalene-2yl) or n-(5-heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain
06/03/2010US20100137320 Gamma secretase modulators
06/03/2010US20100137319 Pyrrolotriazine compounds useful as kinase inhibitors and methods of treating kinase-associated conditions therewith
06/03/2010US20100137318 Bicyclic heterocyclic compound
06/03/2010US20100137317 1,2-Disubstituted Heterocyclic Compounds
06/03/2010US20100137312 Novel aromatic heterocyclic carboxylic acid amide derivatives useful as potassium channel modulators
06/03/2010US20100137311 Substituted pyrimidine derivatives
06/03/2010US20100137308 Quinoxaline Compounds and Use Thereof
06/03/2010US20100137307 Novel 1,2,3,4,-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced terein and has glucocorticoid receptor-binding activity
06/03/2010US20100137306 Heterocyclic trpv1 receptor ligands
06/03/2010US20100137301 Substituted Indolealkanoic Acids
06/03/2010US20100137296 N-phenyl anthranilic acid derivatives and uses thereof
06/03/2010US20100137295 3-substituted-[1,2,3]-benzotriazinone compound for enhancing glutamatergic synaptic responses
06/03/2010US20100137291 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
06/03/2010US20100137288 Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof
06/03/2010US20100137287 Aryl-and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
06/03/2010US20100137286 Arylcyclohexylethers of dihydrotetraazabenzoazulenes
06/03/2010US20100137280 Azetidin compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
06/03/2010US20100137278 Pyrazine compounds as phosphodiesterase 10 inhibitors
06/03/2010US20100137276 Compounds which potentiate ampa receptor and uses thereof in medicine
06/03/2010US20100137275 Triaminopyrimidine derivatives as inhibitors of cdc25 phosphatase
06/03/2010US20100137274 Rivaroxaban and derivatives, synthesis; atherosclerosis; arthritis; Alzheimer's disease or cancer
06/03/2010US20100137273 Novel 2-Azetidinone Derivatives As Cholesterol Absorption Inhibitors For The Treatment Of Hyperlipidaemic Conditions
06/03/2010US20100137259 Compound for inhibiting trpa1 function and use thereof
06/03/2010US20100137258 Thiophosphi(o)nic acid derivatives and their therapeutical applications
06/03/2010US20100137251 Functional Role for Cannabinoids in Autonomic Stability During Sleep
06/03/2010US20100137244 Preparation and utility of hmg-coa reductase inhibitors
06/03/2010US20100137224 Method of reducing injury to mammalian cells
06/03/2010US20100137215 Novel tetrahydro-1h-pyrido[4,3-b]indoles
06/03/2010US20100137196 Histone deacetylases, and uses related thereto
06/03/2010US20100137194 Plasminogen Activator Inhibitor-1 Inhibitors and Methods of Use Thereof to Modulate Lipid Metabolism
06/03/2010US20100136623 Mutations in ion channels
06/03/2010US20100136575 B7-related nucleic acids and polypeptides useful for immunomodulation
06/03/2010US20100136522 Endogenous retroviruses up-regulated in prostate cancer
06/03/2010US20100136122 Oral Preparation Comprising Pioglitazone
06/03/2010US20100136118 Calcium absorption enhancer
06/03/2010US20100136104 Nutritional supplement for use under physiologically stressful conditions
06/03/2010US20100136081 Hyaluronic acid derivative and neural stem cells for sci and pnt regeneration
06/03/2010US20100136062 Use of epidermal growth factor for the morphofunctional restoration of peripheral nerves in diabetic neuropathy
06/03/2010US20100136030 Antagonist ox40 antibodies and their use in the treatment of inflammatory and autoimmune diseases
06/03/2010US20100136024 Selective Inhibition of Histone Deacetylase 6 for Ocular Neuroprotection or for Treatment or Control of Glaucoma
06/03/2010US20100136007 Csf1r extracellular domain fusion molecules and treatments using same
06/03/2010US20100136004 Compositions and methods for treating neurological disorders
06/03/2010US20100135980 Therapeutic and prophylactic uses of cell specific carbonic anhydrase enzymes in treating aging, disorders of aging, cancer, as growth factors, and as an alternative to stem cell therapy
06/03/2010US20100135968 Oligodendrocyte Production From Multipotent Neural Stem Cells
06/03/2010US20100135956 Steroid modulators of progesterone receptor and/or glucocorticoid receptor
06/03/2010US20100135911 Spatial evolution of neural activity
06/03/2010CA2745620A1 Transformed soybean plant which accumulates vaccine, and use thereof
06/03/2010CA2745004A1 Pyridine-3-carboxyamide derivative
06/03/2010CA2744857A1 Cyclobutyl purine derivative, angiogenesis promoting agent, lumen formation promoting agent, neurocyte growth promoting agent, and drug
06/03/2010CA2744819A1 A new family of pain producing substances and methods to produce novel analgesic drugs
06/03/2010CA2744178A1 Indole derivatives, method for preparing same and pharmaceutical compositions containing same
06/03/2010CA2744138A1 Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
06/03/2010CA2743241A1 6,7,8,9-tetrahydro-5h-1,4,7,10a-tetraaza-cyclohept[f]indene derivatives, pharmaceutical compositions containing these compounds, their use and processes for preparing them
06/03/2010CA2742621A1 Plant extract compositions for affecting sleep
06/03/2010CA2741731A1 Compositions of a 5-ht2a serotonin receptor modulator useful for the treatment of disorders related thereto
06/03/2010CA2741303A1 Substituted pyrazoloquinolines and derivatives thereof
06/02/2010EP2192109A1 Bicyclic -amino acid derivative
06/02/2010EP2191846A1 Method for treating pain by administering a nerve growth factor antagonist and an NSAID and composition containing the same
06/02/2010EP2191836A1 Prophylactic or alleviating agent for peripheral nerve disorder induced by anti-cancer agent
06/02/2010EP2191832A1 Quinazoline derivatives which promote the release of parathyroid hormone
06/02/2010EP2191830A1 Solid preparation comprising npyy5 receptor antagonist
06/02/2010EP2190868A2 Methods of inhibiting calcineurin with apoe analogs
06/02/2010EP2190849A2 Compounds useful as protein kinases inhibitors
1 ... 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 ... 1833